IncFact
Company Profiles: Revenue, Growth, Competition

Bicara Therapeutics Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Bicara Therapeutics

Access the complete profile.

Bicara Therapeutics Fast Facts

Revenue$1 - $10 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Address245 Main Street
Cambridge, MA 02142

Note: Revenues for privately held companies are statistical evaluations.


Bicara Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Bicara Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Bicara Therapeutics Annual Revenue and Growth Rate

Bicara Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2025 $1 - $10 million

Details in Premium Report
2024
2023
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Bicara Therapeutics's revenues are gauged from an analysis of company filings.



Bicara Therapeutics's Income Statement (based on Industry Averages)

Bicara Therapeutics P&L$ Millions
Revenue (Sales) Bicara Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Bicara Therapeutics is developing and marketing. Bicara Therapeutics doesn't have any recent trademark applications, indicating Bicara Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
BICARA
anti-cancer pharmaceutical preparations
01/29/2021

See all trademarks and details in the Full Report.


Market Share of Bicara Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Bicara Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSDenver, CO100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM30 
INC RESEARCHRaleigh, NC27 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
SYNEOS HEALTHRaleigh, NC13 
ILLUMINASan Diego, CA12 
UT-BATTELLEOak Ridge, TN11 
PRA HOLDINGSRaleigh, NC11 




Nearby Competitors

These companies are similar in business line and location to Bicara Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
BROAD INSTITUTECambridge, MA100 
BEIGENE USACambridge, MA69 
ALNYLAM PHARMACEUTICALSCambridge, MA52 
SAGE THERAPEUTICSCambridge, MA47 
INTELLIA THERAPEUTICSCambridge, MA35 
IPSEN BIOPHARMACEUTICALSCambridge, MA34 




Other Companies at 245 Main Street, Cambridge MA

Company HeadquartersRevenue ($ MM)
ZOOMRXCambridge, MA100 
SMARTVID.IOCambridge, MA34 
METIS THERAPEUTICSCambridge, MA28 
ENOLINKCambridge, MA27 
APRINOIA THERAPEUTICSCambridge, MA20 


(0.0126 s)



Future Competition: Bicara Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Bicara Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Bicara Therapeutics Competitors